RESUMO
Kasabach-Merritt phenomenon (KMP) is a rare life-threatening vascular condition of infancy. Prognosis factors and long-term follow-up data are lacking. We retrospectively analysed the records of 24 infants (10 females, 14 males) treated for KMP in the Department of Dermatology of Necker-Enfants Malades Hospital, Paris, France, from 1984 to 2012. Mean duration of thrombocytopaenia (2,000-38,000 platelets/mm3, mean 10,500/µl) was 8.8 months (range 3 days-84 months), which correlated with tumour infiltration depth on imaging. D-dimer levels were always elevated, even before KMP onset. Each patient received a mean of 4.8 different treatments (range 1-10). Median follow-up was 6.5 years (range 2 months-22 years). All infants had residual cutaneous lesions, along with inflammatory manifestations (n = 9), elevated D-dimer (n = 5) and orthopaedic sequelae (n = 5). The permanent coagulopathy (elevated D-dimer) even after resolution of KMP suggests the presence of chronic low-grade platelet trapping, with possible sudden worsening, and raises the possibility of prophylactic anti-platelet therapy.
Assuntos
Antineoplásicos/uso terapêutico , Hemangioendotelioma/terapia , Síndrome de Kasabach-Merritt/terapia , Inibidores da Agregação Plaquetária/uso terapêutico , Corticosteroides/uso terapêutico , Biomarcadores/sangue , Biópsia , Coagulação Sanguínea , Terapia Combinada , Embolização Terapêutica , Feminino , Produtos de Degradação da Fibrina e do Fibrinogênio/metabolismo , Hemangioendotelioma/sangue , Hemangioendotelioma/diagnóstico , Hospitais Pediátricos , Humanos , Imuno-Histoquímica , Lactente , Recém-Nascido , Síndrome de Kasabach-Merritt/sangue , Síndrome de Kasabach-Merritt/diagnóstico , Masculino , Invasividade Neoplásica , Contagem de Plaquetas , Estudos Retrospectivos , Fatores de Tempo , Resultado do TratamentoRESUMO
BACKGROUND: Infantile myofibromatosis (IM) is a rare disorder of fibroblastic/myofibroblastic proliferation in children. OBJECTIVES: We sought to document common and unusual characteristics of patients with IM. METHODS: This was a retrospective study of 28 children diagnosed with histopathologically confirmed IM between 1992 and 2012. Epidemiologic, clinical, and treatment data were reviewed. RESULTS: IM was more frequent in boys (60.8%). Skin lesions were congenital in 64.3% of cases. The solitary form accounted for 50% of cases. Most nodules were painless, arising in cutaneous or subcutaneous tissue. The multicentric form accounted for 39% of cases; the skin, subcutaneous tissue, or muscle was involved in 97.8% of cases, and the bones in 50% of cases. The generalized form had a mortality rate of 33% (one-third of cases). Multicentric and generalized forms regressed spontaneously; severe local complications were observed, and late recurrent nodules developed in a few cases. LIMITATIONS: The retrospective review and the ascertainment of patients (from the departments of obstetrics and pediatrics) may have introduced bias in the analysis of severity of the different forms of IM. CONCLUSION: The diagnosis of IM must be confirmed histopathologically because the clinical presentation can be misleading. The prognosis is usually good, although local morbidity can occur. The generalized and multicentric forms merit long-term follow-up.
Assuntos
Miofibromatose/congênito , Neoplasias Cutâneas/patologia , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Miofibromatose/patologia , Remissão Espontânea , Estudos Retrospectivos , Fatores Sexuais , Neoplasias Cutâneas/congênitoAssuntos
Heterozigoto , Mutação , Miofibromatose/congênito , Receptor beta de Fator de Crescimento Derivado de Plaquetas/genética , Biópsia , Análise Mutacional de DNA , Marcadores Genéticos , Predisposição Genética para Doença , Hereditariedade , Humanos , Recém-Nascido , Masculino , Miofibromatose/genética , Miofibromatose/patologia , Linhagem , FenótipoRESUMO
BACKGROUND: Incontinentia pigmenti (IP) is a multisystem disorder, in which cutaneous symptoms can be accompanied by dental, ocular, and central nervous system defects. In adults, the clinical diagnosis of IP is based principally on the late onset of stage 4 lesions and their association with dental, nail, ocular, or central nervous system anomalies. Nevertheless, these lesions are often unrecognized. OBJECTIVES: Our aim was assessment of IP manifestations in adults to clarify diagnostic criteria for mild forms of the disease, to help physicians detect adult IP in the presence of subtle lesions and avoid misdiagnosis. METHOD: We conducted clinical and histologic examination of 25 adults with IP and nuclear factor-κB essential modulator gene rearrangement or mutations. RESULTS: Linear atrophic, hypopigmented, and hairless lesions (stage 4) are constant in adults. Apoptotic keratinocytes in the epidermis or dermis and atrophic hair follicles, with absence of arrector pili muscles, are frequently observed. In contrast, nipple anomalies are rare. LIMITATIONS: We were unable to determine the age of the onset of IP stage 4 lesions. CONCLUSION: Skin manifestations are constant in adult patients with IP. Histology is characteristic and could be considered as a minor diagnostic criterion of IP. Nipple anomalies also may be considered as a minor criterion. Detection of such subtle manifestations can evoke IP in patients with repeated miscarriages or unexplained neurologic manifestations.
Assuntos
Quinase I-kappa B/genética , Incontinência Pigmentar/diagnóstico , Adulto , Idoso , Biópsia , Feminino , Humanos , Incontinência Pigmentar/genética , Incontinência Pigmentar/patologia , Pessoa de Meia-Idade , Mutação , Pele/patologiaRESUMO
BACKGROUND: Ulcerated infantile hemangiomas (IH) are a therapeutic challenge. Propranolol, a nonselective beta-blocker, was recently introduced as a novel treatment for IH. OBJECTIVE: To evaluate our experience of propranolol in the management of ulcerated IH. METHODS: A national, multicenter, retrospective, observational study was conducted. Data were collected from the medical charts of patients treated from 2008 to 2009 and supplemented by information obtained from parents during targeted telephone interviews. RESULTS: Thirty-three infants with propranolol-treated ulcerated IH were included. The average time to complete ulceration healing was 4.3 weeks in 30 of 33 patients and was significantly faster for head-and-neck locations (P = .0354). The mean time to complete pain control was 14.5 days. Parents rated treatment as very effective for 27 of 31 patients and very well tolerated for 29 of 31 cases. LIMITATIONS: This was a retrospective uncontrolled study. CONCLUSION: Propranolol appears to be an effective and well-tolerated treatment for ulcerated IH.
Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Hemangioma/tratamento farmacológico , Hemangioma/patologia , Propranolol/uso terapêutico , Neoplasias Cutâneas/tratamento farmacológico , Antagonistas Adrenérgicos beta/administração & dosagem , Criança , Pré-Escolar , Feminino , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Hemangioma/complicações , Humanos , Masculino , Propranolol/administração & dosagem , Estudos Retrospectivos , Úlcera Cutânea/tratamento farmacológico , Úlcera Cutânea/etiologia , Resultado do Tratamento , Cicatrização/efeitos dos fármacosRESUMO
Highly vascularized malignant soft-tissue tumors can clinically and radiologically mimic deep hemangiomas. We present a case of congenital rhabdomyosarcoma of the neck, which was initially identified as congenital hemangioma.
Assuntos
Erros de Diagnóstico , Neoplasias de Cabeça e Pescoço/diagnóstico , Hemangioma/diagnóstico , Rabdomiossarcoma/diagnóstico , Neoplasias de Tecidos Moles/diagnóstico , Biópsia , Feminino , Hemangioma/congênito , Humanos , Imageamento por Ressonância Magnética , MasculinoAssuntos
Síndrome de Gardner/patologia , Neoplasias Cutâneas/patologia , Doenças Assintomáticas , Biópsia , Pré-Escolar , Códon sem Sentido , Colonoscopia , Análise Mutacional de DNA , Progressão da Doença , Síndrome de Gardner/genética , Genes APC , Predisposição Genética para Doença , Humanos , Imuno-Histoquímica , Masculino , Fenótipo , Neoplasias Cutâneas/genéticaRESUMO
IMPORTANCE: Congenital hemangiomas (CHs) are rare benign vascular tumors that differ from common infantile hemangiomas in that they grow in utero and are fully developed at birth. While ulceration is a common, predominantly benign complication in infantile hemangioma, little is known about the prognosis of ulcerated CH. However, it has been observed that ulcerated CH may be complicated by life-threatening bleeding episodes. OBSERVATIONS: We report 2 cases of ulcerated rapidly involuting congenital hemangiomas (RICH) that were complicated by life-threatening bleeding episodes in the neonatal period. In both cases, the CHs were fed by high-flow vessels and the ensuing massive bleeding was due to superficial vessel wall erosion induced by the ulceration. Both patients were successfully treated with intravascular embolization; one patient underwent additional hemostatic surgery. CONCLUSIONS AND RELEVANCE: These 2 cases highlight the importance of closely monitoring children with ulcerated CH because of the risk of severe bleeding. Embolization is the treatment of choice in the case of severe bleeding, as the natural history of RICH is to spontaneously regress.
Assuntos
Hemangioma/complicações , Hemorragia/etiologia , Úlcera/complicações , Embolização Terapêutica/métodos , Feminino , Hemangioma/congênito , Hemorragia/terapia , Hemostasia Cirúrgica/métodos , Humanos , Recém-Nascido , Masculino , Prognóstico , Índice de Gravidade de Doença , Resultado do Tratamento , Úlcera/etiologiaRESUMO
Ichthyosis is a heterogeneous group of skin disorders characterized by abnormal epidermal scaling. Occasionally, extracutaneous features are associated. A novel autosomal recessive ichthyosis syndrome is described here with scalp hypotrichosis, scarring alopecia, sclerosing cholangitis, and leukocyte vacuolization in two inbred kindreds of Moroccan origin. We also report the mapping of the diseased gene to a 21.2 cM interval of chromosome 3q27-q28. Homo zygosity for polymorphic markers has enabled us to reduce the genetic interval to a 16.2 cM region. Furthermore, comparison of mutant chromosomes in the two families has suggested a common ancestral mutant haplotype. This linkage disequilibrium has reduced the genetic interval encompassing the diseased gene to less than 9.5 cM maximum. Further study of additional families from the same geographic area will hopefully reduce the genetic interval as well as help in the cloning of the gene involved in this rare disorder.
Assuntos
Cromossomos Humanos Par 3 , Ictiose/genética , Adolescente , Criança , Pré-Escolar , Colangite Esclerosante/genética , Colangite Esclerosante/patologia , Mapeamento Cromossômico , Consanguinidade , Saúde da Família , Feminino , Efeito Fundador , Homozigoto , Humanos , Hipotricose/genética , Hipotricose/patologia , Ictiose/patologia , Queratinócitos/patologia , Leucócitos/patologia , Masculino , Marrocos , Linhagem , Couro CabeludoRESUMO
Netherton syndrome is a severe autosomal recessive skin disorder characterized by congenital erythroderma, a specific hair-shaft abnormality, and atopic manifestations with high IgE levels. Recently, we identified SPINK5, which encodes the serine protease inhibitor Kazal-type 5 protein (LEKTI), as the defective gene in Netherton syndrome. Here we describe the intron-exon organization of the gene and characterize the SPINK5 mutations in patients from 21 families of different geographic origin, using denaturing high performance liquid chromatography and direct sequencing. We identified 18 mutations, of which 13 were novel and seven (39%) were recurrent. The majority of the mutations were clustered between exons 1-8 and exons 21-26. They comprised four nonsense mutations (22%), eight frameshift insertions or deletions (44%), and six splice-site defects (33%). All mutations predict the formation of premature termination codons. Northern blot analysis showed variable reduction of SPINK5 mutant transcript levels, suggesting variable efficiency of nonsense-mediated mRNA decay. Seven patients were homozygotes, eight were compound heterozygotes, and five were heterozygotes with only one identifiable SPINK5 mutation. Five mutations, one of which resulted in perinatal lethal disease in three families, were associated with certain ethnic groups. We also describe 45 intragenic polymorphisms in the patients studied. The clinical features of erythroderma, trichorrhexis invaginata, and atopic manifestations were present in the majority of affected individuals and ichthyosis linearis circumflexa was seen in 12 out of 24 patients. Interfamilial and intrafamilial variation in disease severity was observed, with no clear correlation between mutations and phenotype, suggesting that the degree of severity may be affected by other factors.
Assuntos
Proteínas de Transporte , Cabelo/anormalidades , Hipersensibilidade/genética , Eritrodermia Ictiosiforme Congênita/genética , Mutação/genética , Inibidores de Serina Proteinase/genética , Adolescente , Adulto , Criança , Pré-Escolar , Códon sem Sentido/genética , Anormalidades Congênitas/genética , Elementos de DNA Transponíveis , Éxons/genética , Deleção de Genes , Genoma , Genótipo , Humanos , Lactente , Dados de Sequência Molecular , Polimorfismo Genético/genética , Proteínas Secretadas Inibidoras de Proteinases , Sítios de Splice de RNA/genética , RNA Mensageiro/metabolismo , Inibidor de Serinopeptidase do Tipo Kazal 5 , SíndromeRESUMO
BACKGROUND: Incontinentia pigmenti (IP) is an X-linked genodermatosis that is manifested by neonatal inflammatory vesicles localized along the lines of Blaschko. These lesions usually clear spontaneously within a few months, leaving hyperpigmentation. Ophthalmologic and neurologic symptoms can be associated with IP. Late recurrences of the first-stage inflammatory lesions after the initial rash are uncommon and have been reported infrequently. The mechanism involved in this phenomenon is unclear. However, the recent identification of NEMO/IKKgamma as the gene responsible for IP sheds new light on its pathophysiologic origins. OBSERVATIONS: We report 5 cases of children who experienced episodes of late reactivation of IP. In all cases, the recurrences occurred on the previously hyperpigmented streaks several months or years after resolution of the initial eruptions. In most cases, the recurrences were preceded by an infectious episode. CONCLUSIONS: These IP recurrences suggest that mutated cells can persist a long time in the epidermis. We theorize that infections trigger the reactivations. The NEMO/IKKgamma gene encodes a protein essential in nuclear factor kappaB activation, which is required for resistance to tumor necrosis factor alpha-induced apoptosis. We discuss the role of a proinflammatory cytokine such as tumor necrosis factor alpha as a triggering factor for the reactivation.
Assuntos
Incontinência Pigmentar/patologia , Inflamação/patologia , Biópsia por Agulha , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Incontinência Pigmentar/fisiopatologia , Lactente , Recidiva , Fatores de Risco , Estudos de Amostragem , Índice de Gravidade de Doença , Dermatopatias Genéticas/patologia , Dermatopatias Genéticas/fisiopatologia , Fatores de TempoRESUMO
OBJECTIVE: To analyze the distribution of manifestations in a pediatric cohort and define guidelines for follow-up of incontinentia pigmenti (IP). DESIGN: Retrospective study of 47 children referred to the Department of Pediatric Dermatology with a diagnosis of IP between 1986 and 1999. SETTING: The private or institutional practice of participating dermatologists and pediatricians. MAIN OUTCOME MEASURES: Evaluation of IP clinical diagnosis using the Landy and Donnai criteria. RESULTS: Because hyperpigmentation following the Blaschko lines may be observed in several pigmented disorders, 7 patients were found misdiagnosed. During the neonatal period, erythema, vesicles, and hyperkeratotic le sions were rarely absent in the patients with IP. Ocular and neurological abnormalities were frequent (20% and 30%, respectively) but rarely severe (8% and 7.5%, respectively). CONCLUSIONS: Clinical diagnosis is the first main step for a correct phenotype/genotype correlation, which remains indispensable to better understand the pathological mechanisms of IP and develop new therapies. In doubtful cases, molecular analysis is helpful but characteristic histological features must be added as major criteria for IP diagnosis. Multidisciplinary follow-up is needed, particularly during the first year of life, to detect possible ophthalmologic and neurological complications. Neuroimaging ought to be performed in the case of abnormal neurological examination results or when vascular retinopathy is detected.
Assuntos
Incontinência Pigmentar/diagnóstico , Incontinência Pigmentar/terapia , Guias de Prática Clínica como Assunto/normas , Padrões de Prática Médica/normas , Criança , Pré-Escolar , Estudos de Coortes , Diagnóstico Diferencial , Feminino , Humanos , Incontinência Pigmentar/complicações , Lactente , Recém-Nascido , Masculino , Estudos Retrospectivos , Índice de Gravidade de DoençaRESUMO
OBJECTIVES: To verify the diagnostic value of lumbosacral midline cutaneous lesions in asymptomatic children to detect occult spinal dysraphism (OSD) and to propose a practical approach for clinical investigations with respect to the type of cutaneous lesions observed. DESIGN: Retrospective study of 54 children referred to the Department of Pediatric Dermatology between 1990 and 1999 for congenital midline lumbosacral cutaneous lesions. SETTING: The private or institutional practices of participating dermatologists and pediatricians. MAIN OUTCOME MEASURES: Evaluation of the diagnostic value of midline cutaneous lesions for the detec-tion of OSD. Association of skin examination findings with spinal anomalies detected by magnetic resonance imaging or ultrasound. RESULTS: Occult spinal dysraphism was detected in 3 of 36 patients with an isolated congenital midline lesion and 11 of 18 patients with a combination of 2 or more different skin lesions. CONCLUSIONS: A combination of 2 or more congenital midline skin lesions is the strongest marker of OSD. Careful dermatologic examination is needed to detect suggestive markers and request a spinal magnetic resonance image, which is the most sensitive radiologic approach to detect an OSD.
Assuntos
Anormalidades da Pele/diagnóstico , Espinha Bífida Oculta/diagnóstico , Adolescente , Criança , Pré-Escolar , Feminino , Hemangioma Capilar/congênito , Hemangioma Capilar/diagnóstico , Humanos , Lactente , Recém-Nascido , Imageamento por Ressonância Magnética , Masculino , Mancha Vinho do Porto/diagnóstico , Prognóstico , Estudos Retrospectivos , Sensibilidade e Especificidade , Anormalidades da Pele/cirurgia , Espinha Bífida Oculta/cirurgia , Disrafismo Espinal/diagnóstico , Disrafismo Espinal/cirurgia , Resultado do Tratamento , Ultrassonografia DopplerRESUMO
Plexiform neurofibromas (PNs) are common and potentially debilitating complications of neurofibromatosis 1 (NF1). These benign nerve-sheath tumors are associated with significant pain and morbidity because they compress vital structures. The mammalian target of rapamycin (mTOR) pathway is a major mediator involved in tumor growth in NF1. We present 3 cases of patients with NF1, aged 8, 16, and 17 years, followed for inoperable and symptomatic PNs; patients received sirolimus for life-threatening and painful neurofibromas after multidisciplinary consultation. Epidemiologic, clinical, and radiologic data were retrospectively collected. The volume of PNs did not differ between baseline and 12-month follow-up and pain was alleviated, with withdrawal of analgesics in 2 cases at 6 months, and significantly decreased for the third case. Sirolimus for inoperable symptomatic PNs in patients with NF1 permitted stabilization of mass and produced unpredictable and important alleviation of pain in all cases with good tolerance. This treatment was proposed in extreme cases, in absence of therapeutic alternatives, after multidisciplinary consensus. The mTOR pathway may be both a major mediator of NF1 tumor growth and regulator of nociceptor sensitivity. mTOR inhibitors clinically used as anticancer and immunosuppressant drugs could be a potential treatment of chronic pain.
Assuntos
Neoplasias Abdominais/tratamento farmacológico , Dor Crônica/tratamento farmacológico , Neurofibroma Plexiforme/tratamento farmacológico , Neurofibromatose 1/tratamento farmacológico , Sirolimo/uso terapêutico , Neoplasias Abdominais/diagnóstico , Adolescente , Criança , Dor Crônica/diagnóstico , Comportamento Cooperativo , Relação Dose-Resposta a Droga , Esquema de Medicação , Feminino , Seguimentos , Humanos , Comunicação Interdisciplinar , Masculino , Neurofibroma Plexiforme/diagnóstico , Neurofibromatose 1/diagnóstico , Medição da Dor/efeitos dos fármacos , Sirolimo/efeitos adversosRESUMO
BACKGROUND: Tufted angioma (TA) is a rare benign vascular tumor that mostly appears during infancy or early childhood. Histologic tufts of capillaries infiltrating the whole dermis in a "cannonball" distribution pattern associated with dilated lymphatic vessels are characteristic of the disease and confirm the diagnosis. Few case series of TA have been published, and the morphologic structure and evolution of TA seem to vary. OBSERVATIONS: We describe the largest series to date of childhood TA, comprising 13 cases. All children developed lesions within the first year of life; 7 cases were congenital. We found a clear male predominance (9 of 13 children). Presentation was a nascent or florid tumor, usually a dusky red to violaceous plaque, that was indurated, firm, and sometimes associated with hyperhidrosis or hypertrichosis. Locations of the lesions included limbs, abdomen, and genitalia. Five children had spontaneous regression, 5 children had Kasabach-Merritt syndrome, and 1 child had a lesion that stabilized. Two children with painful TA had chronic coagulopathy without thrombocytopenia that was controlled by ticlopidine hydrochloride and aspirin. CONCLUSIONS: The following 3 clinical patterns could be distinguished: TA without complications, TA complicated by Kasabach-Merritt syndrome, and TA without thrombocytopenia but with chronic coagulopathy. To our knowledge, this study is the first to describe the third pattern. Because of the aggressive nature of Kasabach-Merritt syndrome, it is essential to obtain a complete blood cell count when evaluating a child with TA.
Assuntos
Hemangioma/patologia , Neoplasias Cutâneas/patologia , Pele/patologia , Adolescente , Criança , Pré-Escolar , Diagnóstico Diferencial , Feminino , Seguimentos , Humanos , Masculino , Estudos Retrospectivos , Adulto JovemRESUMO
BACKGROUND: Plexiform fibrohistiocytic tumor is a soft-tissue tumor of intermediate malignancy occurring in children and young adults but is only rarely found in infants. The tumor usually involves the upper limbs and is slow growing and painless. Recurrence rate is high. Lymph node and systemic metastases can occur, but have never been reported in infants. Clinical behavior in infancy is not known. Histologically, the tumor is characterized by nodules of histiocyte-like and multinucleated cells and fascicles of spindle cells arranged in a plexiform pattern. Mitosis, atypia, and nuclear pleomorphism are common but not pronounced. METHODS AND RESULTS: We report three cases in infants, one of which is congenital, having an unusual topography and a broad histological spectrum. CONCLUSION: In infants, wide excision with large safety margins should be performed as the behaviour of this tumor remains uncertain. Leclerc S, Hamel-Teillac D, Oger P, Brousse N, Fraitag S. Plexiform fibrohistiocytic tumor: three unusual cases occurring in infancy.
Assuntos
Histiocitoma Fibroso Benigno/patologia , Neoplasias de Tecidos Moles/patologia , Biomarcadores Tumorais/análise , Feminino , Histiocitoma Fibroso Benigno/química , Histiocitoma Fibroso Benigno/cirurgia , Humanos , Técnicas Imunoenzimáticas , Lactente , Masculino , Neoplasias de Tecidos Moles/química , Neoplasias de Tecidos Moles/cirurgia , Resultado do TratamentoRESUMO
BACKGROUND AND AIMS: Most human and animal cholestatic disorders are associated with changes in hepatocyte cytoskeleton and tight junctions (TJs). These changes are usually secondary and nonspecific phenomena, both in intra- and extrahepatic cholestasis. Recently, missense mutations in TJ protein 2 (ZO-2) have been identified in patients with familial hypercholanemia. In the liver, TJs separate bile flow from plasma and are composed of strands of claudins and occludin. We previously assigned a syndrome associating ichthyosis and neonatal sclerosing cholangitis (NISCH syndrome) to chromosome 3q27-q28. We considered claudin-1 to be a strong candidate gene based on its mapping to the minimum interval and on the expression pattern of the mouse ortholog. METHODS: The 4 exons and intron-exon junctions of claudin-1 gene were amplified using standard polymerase chain reaction protocols and specific primers. Western blot analysis on cultured fibroblasts and immunohistochemistry on liver tissue section were performed using rabbit anti-claudin-1 antibodies. RESULTS: We described in 4 patients, of 2 inbred kindred of Moroccan origin, a 2-bp deletion (200-201 TT) in exon 1 of the claudin-1 gene arising in a premature stop codon and resulting in total absence of claudin-1 protein in the liver and skin. CONCLUSIONS: Lack of claudin-1 in NISCH syndrome may lead to increased paracellular permeability between epithelial cells. Bile duct injury may be related to the absence of claudin-1 expression in cholangiocytes. Our observation, in conjunction with ZO-2-associated hypercholanemia, emphasizes the role played by TJ components in hereditary cholestasis.